All News

 

BlackRock Commentary: Positioning for the new nominal

A key consequence of this year’s policy revolution is the potential for a more muted response of nominal yields to higher inflation, in BlackRock’s view. This means investors should start positioning their long-term portfolios for this new dynamic now, in their view.

Notes from the Trading Desk – Franklin Templeton

This week’s update will be discussing Brexit that has an ultimate deadline of the 31 December. With regards to COVID-19, we will see how the US Food and Drug Administration approved the Pfizer COVID-19 vaccine last week (on the heels of the UK’s vaccine approval) but cases continue to rise in Europe and the United States.

bonds

Liontrust Insights: 12 Myths of Bonds

There are many misconceptions about the bond market and the forces that drive it. In this article, David Roberts from Liontrust tackles 12 of the biggest current myths of investing in bonds.

BlackRock Commentary: Why we are turning bullish for 2021

The expected widespread rollout of Covid-19 vaccines in 2021 has strengthened BlackRock’s conviction in an accelerated economic restart. They have turned more pro-risk, upgrading equities to a tactical overweight. This pro-risk stance is becoming consensus, but the rest of their views are much less so.

BlackRock Commentary: Our latest credit views

BlackRock have closed our tactical underweight in EM debt as easy monetary policy is expected to stay, against the background of an improved 2021 outlook. Positive news on Covid vaccine development has boosted the case for an accelerated global restart in 2021.

Facebook
4/5
4.2
Apple Store
4/5
4.2
Play Store
4/5
4.2

Experience better banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. Sign up and open your account for free, within minutes.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.